July 2018
Volume 59, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2018
Predictor Intake Form with OCTA Validation in Type I Diabetic Retinopathy Triage
Author Affiliations & Notes
  • Hadeel Sadek
    Rutgers New Jersey Medical School, Newark, New Jersey, United States
  • Subhashini Chandrasekaran
    Rutgers New Jersey Medical School, Newark, New Jersey, United States
  • Rich Amador
    IOVS, Newark, New Jersey, United States
  • Peter Khouri
    IOVS, Newark, New Jersey, United States
  • Bernard Szirth
    IOVS, Newark, New Jersey, United States
  • Footnotes
    Commercial Relationships   Hadeel Sadek, None; Subhashini Chandrasekaran, None; Rich Amador, Canon Inc. (E); Peter Khouri, None; Bernard Szirth, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 2791. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hadeel Sadek, Subhashini Chandrasekaran, Rich Amador, Peter Khouri, Bernard Szirth; Predictor Intake Form with OCTA Validation in Type I Diabetic Retinopathy Triage. Invest. Ophthalmol. Vis. Sci. 2018;59(9):2791. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The prevalence of T1DM in the US is 1.25 million. The aim is to create a triage intake form that can identify and prioritize high risk individuals for the development of diabetic retinopathy (DR) based on their scores, who could benefit from earlier than yearly recommended eye screenings.

Methods : Thirty-eight subjects (14 male, 24 female) with T1DM were selected from a comprehensive non-mydriatic tele-retinal screening. Subjects ranged from 10 to 72 years old (avg=27y) with a duration of T1DM > or = 1.5 years (avg=14.5y). Subjects were split into two T1DM groups: those with (N=19) and those without (N=19) dot hemorrhages, flame hemorrhages, or intraretinal microvascular abnormalities (IRMAs) on color retinal imaging. A control group without diabetes (N=19) underwent an identical questionnaire (< 5 min to complete). Each individual received a score based on their responses, placing emphasis on risk factors for DR, such as last blood glucose level, HbA1C, BMI, blood pressure, diet, and duration of T1DM. Low risk: 14, pre-risk: 20, high risk: 24. The findings were validated with color imaging, fundus autofluorescence (FAF), and optical coherence tomography angiography (OCTA). One-way ANOVA and Tukey post-hoc tests were used to determine the threshold for each of the 3 groups.

Results : Scoring was: 24 for subjects with DR, 20 for subjects with diabetes and no DR, and 14 for subjects without diabetes. One-way ANOVA showed a significant difference between average scores of the 3 groups (p= 2.94 x 10-7). Tukey post-hoc tests showed significant difference between scores of the subjects with diabetes and no DR and subjects without diabetes (p=0.0007) and significant difference between the subjects with DR and subjects without diabetes (p= 2 x10-6). There was no significant difference between subjects with DR and subjects with diabetes and no DR (p= 0.056) when looking at only color retinal images.

Conclusions : Use of triage form may be beneficial at screenings to prioritize individuals with higher risk for DR (score >22) who need to be screened first. It may also be beneficial to track an individual’s risk change prior to follow-up visits. Further investigation must be performed on a larger population and utilizing a more sensitive imaging modality, such as OCTA, that can help confirm earlier changes.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×